Organ-specific response to nivolumab in patients with non-small cell lung cancer (NSCLC)

ConclusionIn conclusion, the efficacy of immunotherapy is dependent on the metastatic location. Treatment appears more active in lymph nodes compared to other organ sites such as liver, adrenals and bone. Future strategies may include additional local treatment in case of oligoprogression in these organs in patients with otherwise sustained treatment benefit.
Source: Cancer Immunology, Immunotherapy - Category: Cancer & Oncology Source Type: research